BeStock  
Stocks › Biotechnology › IBRX

ImmunityBio IBRX

US equityMarket cap rank #1801BiotechnologyTop Gainers Yesterday
$6.02 −$0.55 (-8.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.08 +1.08%
Open$6.41
Prev close$6.57
Day range$6.00 – $6.53
Volume10.64M
Market cap$6.40B
P/E (TTM)–
Dividend yield–

IBRX Stock News

Headlines matching ImmunityBio or the IBRX ticker, most recent first.

  • Piper Sandler Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $12Market news · 8 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $15Market news · 5 Aug 2026 · Direct mention
  • BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $12Market news · 5 Aug 2026 · Direct mention
  • Earnings Flash (IBRX) ImmunityBio Posts Q2 Net Loss $0.22 a Share, Vs. FactSet Est of $0.08 Loss NegativeMT Newswires · 4 Aug 2026 · Direct mention
  • BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Cuts Target Price to $12 NegativeMarket news · 8 May 2026 · Direct mention
  • ImmunityBio (IBRX) Receives a Buy From H.C. WainwrightTipRanks · 8 May 2026 · Direct mention
  • H.C. Wainwright Sticks to Its Buy Rating for ImmunityBio (IBRX)TipRanks · 30 Apr 2026 · Direct mention
  • Piper Sandler Maintains ImmunityBio(IBRX.US) With Buy Rating, Raises Target Price to $12 PositiveMarket news · 4 Mar 2026 · Direct mention
  • BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $13Market news · 25 Mar 2026 · Direct mention
  • BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Raises Target Price to $13 PositiveMarket news · 12 Mar 2026 · Direct mention
  • BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $9Market news · 3 Feb 2026 · Direct mention
  • H.C. Wainwright Maintains ImmunityBio(IBRX.US) With Buy Rating, Raises Target Price to $15 PositiveMarket news · 24 Feb 2026 · Direct mention
  • H.C. Wainwright Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $10Market news · 19 Feb 2026 · Direct mention
  • Earnings Flash (IBRX) ImmunityBio Posts Q3 Net Loss $0.18 a Share, Vs. FactSet Est of $0.07 Loss NegativeMT Newswires · 9 Nov 2026 · Direct mention
  • Divergence in Insider Trading Among U.S. Biotech Stocks: ImmunityBio (IBRX.US) Sees Largest Cash-Out, While Sellas (SLS.US) Directors Buy In Before 5-Fold Surge PositiveZhitong Finance · 12 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IBRX.

Sign in to join the discussion.

Scroll to Top